Skip to main content
RAPS Convergence 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Requires Pre-Registration or Sign-up
Requires Pre-Registration or Sign-up
Additional Registration Fee
Additional Registration Fee
Invitation Only
Invitation Only
Student Program
Student Program
Networking Opportunity
Networking Opportunity
RAPS Focus Area
RAPS Focus Area
Back

Iordanis Gravanis, MD, PhD

Head of Scientific Advice
European Medicines Agency, Netherlands

Iordanis Gravanis is the Head of the Scientific Advice Office at the European Medicines Agency which coordinates the provision of scientific and regulatory support by the Scientific Advice Working Party (SAWP) of the Committee for Medicines for Human Use (CHMP) to the development of new and existing medicines and to novel methodologies used in drug development. He has been at the EMA for 15 years, having worked initially in the Oncology Office as EMA Product Team Leader and afterwards in a management role aiming to improve medicines authorisation and post-authorisation processes and the EMA IT tools which support such processes. He has been heading the Scientific Advice Office since early 2020. Iordanis holds a medical degree from the University of Ioannina, Greece and a PhD in Molecular and Cellular Pharmacology from Stony Brook University, NY, USA. His thesis research revolved around neurodegenerative models of excitotoxicity in mice.

Disclosure information not submitted.

Presentation(s):